Manipal Health IPO Listing: Shares Debut With 11% Gain at ₹655; Check Company’s Valuation

Manipal Health IPO investors received a major surprise on the listing day as Manipal Health shares made a strong debut on the stock exchanges. The stock listed at a premium of around 11%, outperforming the relatively muted expectations indicated by Grey Market Premium (GMP) trends before listing.

The strong market debut has brought significant gains for investors who received shares in the IPO at the issue price. The stock continued to trade above its issue price on both the NSE and BSE, despite some minor profit-booking after the initial listing.

Manipal Health Share Price on NSE

On the National Stock Exchange (NSE), Manipal Health shares were trading at around ₹653.

The stock was approximately ₹1, or 0.15%, above its opening price of ₹652.

Compared with the IPO issue price of ₹590, the stock was trading around ₹63 higher, representing a gain of approximately 10.68% for IPO investors.

This means investors who received one lot at the issue price saw a substantial listing-day gain, depending on the number of shares allotted.

Manipal Health Shares on BSE

On the Bombay Stock Exchange (BSE), the stock was trading around ₹652.65.

The shares witnessed minor profit-booking of approximately ₹2.35, or 0.36%, from the opening level. However, the stock remained well above its IPO issue price.

At ₹652.65, Manipal Health shares were approximately ₹62.65, or 10.62%, higher than the issue price of ₹590.

Manipal Health IPO Beats GMP Expectations

Before the listing, Grey Market Premium (GMP) trends had indicated a relatively moderate debut for Manipal Health shares. However, the actual listing performance was significantly stronger.

The stock entered the market with a premium of around 11%, exceeding the expectations based on pre-listing market trends.

The strong debut reflects investor interest in the healthcare sector and optimism surrounding Manipal Health's business prospects.

What Does the Strong Listing Mean for IPO Investors?

For investors who received an allotment in the Manipal Health IPO, the listing has delivered a healthy immediate gain.

At a market price of around ₹653, investors are sitting on a gain of roughly ₹63 per share compared with the ₹590 issue price.

However, investors should remember that a strong listing does not guarantee continued gains. Share prices can remain volatile after an IPO, particularly as early investors may book profits.

Manipal Health IPO Listing:                    Key Numbers

Particular                                                Details

IPO Issue Price                                        ₹590

NSE Price                                                ₹653

NSE Gain vs Issue Price                       ₹63 (10.68%)

BSE Price                                               ₹652.65

BSE Gain vs Issue Price                      ₹62.65 (10.62%)

Listing Performance Around                 11% Premium

Manipal Health IPO listing has turned out to be much stronger than expected. Shares gained around 11% over the IPO issue price, giving allotted investors a healthy listing-day return.

The stock's performance on the NSE and BSE will now be closely watched as investors assess whether the strong debut can translate into sustained gains in the coming trading sessions.